MedMen

Week in Review: Marijuana RICO case victory, MedMen eyes ‘cannabis’ trademark & CA issues first full annual permits

A Colorado marijuana grower wins a milestone racketeering case, MedMen seeks a trademark for the word “cannabis,” and California issues its first full annual MJ business licenses. Here’s a closer look at some notable developments in the marijuana industry this week. Big legal victory Legal experts said marijuana growers can rest a little easier after a […]

Read More

MedMen pens $33 million deal to expand its reach in Arizona cannabis market

Los Angeles-based MedMen inked a $33 million deal to acquire an Arizona-based vertically integrated marijuana firm. The cash and stock deal will give MedMen a controlling interest in cannabis cultivator, producer and retailer Kannaboost Technology and CSI Solutions – referred to collectively as Level Up. Here are the basics behind the deal: MedMen expands its […]

Read More

MedMen seeks to trademark the word ‘cannabis’ for T-shirts

California-based MedMen Enterprises has filed an application to trademark the word “cannabis” for use on T-shirts, but a trademark specialist is skeptical the application will fly with the federal government. The application, filed in early October with the U.S. Patent and Trademark Office (USPTO), follows the multistate cannabis company’s successful effort to trademark a marijuana […]

Read More

Southern California recreational cannabis firms struggle with product shortages, licensing and black market

“Growing pains” is an understatement to describe Southern California’s tumultuous recreational marijuana marketplace. New regulations that took effect July 1 are rattling what was already a turbulent part of the California MJ industry. The industry there also is suffering from product shortages, slow license approvals and a thriving black market. Moreover, Southern California adult-use cannabis businesses […]

Read More

MedMen inks blockbuster $682 million stock deal to acquire medical cannabis firm PharmaCann

MedMen Enterprises has agreed to acquire multistate medical marijuana company PharmaCann in an all-stock deal valued at $682 million, inking what is believed to be the largest acquisition to date in the U.S. cannabis industry. The deal will double the number of states where Los Angeles-based MedMen has licenses to operate – expanding the firm’s […]

Read More

MedMen inks dispensary deal to enter Illinois medical cannabis market

Los Angeles-based MedMen announced its second acquisition of the week to expand its national footprint – this time into the Illinois medical marijuana market. The multistate marijuana business agreed to acquire Seven Point, a licensed medical cannabis dispensary in the Chicago suburb of Oak Park. Terms of the deal weren’t disclosed, but it comes on the heels […]

Read More

MedMen expands into Arizona medical marijuana market via acquisition

Los Angeles-based MedMen Enterprises is expanding  into Arizona’s large medical marijuana market after striking a deal with WhiteStar Solutions to acquire Monarch, a vertically integrated MMJ business with operations in Scottsdale and Mesa. The deal – inked for an undisclosed sum – will pay 80% in stock and 20% in cash and underlines the fact investors […]

Read More

Week in Review: MJardin’s reverse takeover, California’s marijuana testing woes & Alaskans’ taste for high-THC goods

MJardin becomes the latest U.S. cannabis company to go public in Canada through a reverse takeover, nearly 20% of marijuana products in California fail tests for potency and purity, and Alaskans’ preference for high-THC products could bankrupt some growers. Here’s a closer look at some notable developments in the cannabis industry this week. Buyer beware […]

Read More

Weekly Deal Watch: Cannabis investing and M&A highlights (as of Sept. 7, 2018)

This is the first installment of a new weekly series from Marijuana Business Daily and Viridian Capital Advisors. Each week, we will provide you with the latest data on cannabis investment activity and M&A, along with key takeaways, analysis and trends based on recent market moves. The data below, provided by Viridian Capital Advisors, is through the week […]

Read More